Related Experiment Videos
Cutaneous sarcoidosis successfully treated with topical tacrolimus
1Department of Dermatology, Kyoto Prefectural University of Medicine, 465 Kawaramachi-Hirokoji, Kamigyo-ku, Japan. nkatoh@koto.kpu-m.ac.jp
The British Journal of Dermatology
|July 9, 2002
Summary
Topical tacrolimus effectively treated facial sarcoidosis plaques in a 62-year-old woman. This immunosuppressive ointment offered a successful alternative when corticosteroids failed, with no observed adverse effects.
Area of Science:
- Immunodermatology
- Autoimmune Disorders
- Clinical Case Study
Background:
- Sarcoidosis is an inflammatory condition involving macrophage and T-cell responses to unknown triggers.
- Cutaneous sarcoidosis presents as various skin lesions, often on the face.
- Standard treatments include corticosteroids, which may have limitations or side effects.
Observation:
- A 62-year-old woman presented with a decade-long history of distinctive orange-yellow facial plaques.
- Previous treatments with topical and systemic corticosteroids were ineffective for her cutaneous sarcoidosis.
- The patient's skin lesions showed significant improvement upon application of topical tacrolimus ointment.
Findings:
- Topical tacrolimus demonstrated efficacy in resolving chronic facial sarcoidosis plaques.
- The treatment was well-tolerated, with no adverse effects reported by the patient.
- This case highlights tacrolimus as a potential therapeutic option for refractory cutaneous sarcoidosis.
Implications:
- Topical tacrolimus may represent a valuable alternative treatment for patients with sarcoidosis affecting the skin, especially when conventional therapies fail.
- Further research into the immunomodulatory mechanisms of tacrolimus in sarcoidosis is warranted.
- This finding could lead to improved management strategies for sarcoidosis patients experiencing treatment-resistant skin manifestations.